HC Wainwright & Co. Reiterates Buy on InflaRx, Maintains $8 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White has reiterated a Buy rating on InflaRx (NASDAQ:IFRX) and maintained an $8 price target.

March 22, 2024 | 12:22 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
InflaRx maintains a Buy rating and an $8 price target from HC Wainwright & Co., as reiterated by analyst Edward White.
The reiteration of a Buy rating and maintenance of an $8 price target by a reputable analyst firm like HC Wainwright & Co. typically signals a positive outlook on the stock, suggesting potential upside. This can positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100